Podcast appearances and mentions of James Kirkland

Play Episode Listen Later Mar 9, 2022 9:01

In this video Dr. Kirkland talks about the future of aging and how the biology of aging affects everyone and should not be thought of as only relevant to older people. He also discusses the path of bringing senolytics to wider use. Dr. James Kirkland is Director of the Robert and Arlene Kogod Center on Aging at Mayo Clinic and Noaber Foundation Professor of Aging Research. Dr. Kirkland's research focuses on cellular senescence, age-related adipose tissue and metabolic dysfunction, and development of agents and strategies for targeting fundamental aging mechanisms to treat age-related chronic diseases and disabilities and to extend healthspan. He published the first article about drugs that clear senescent cells, senolytic agents. A novel, mechanism-based, hypothesis-driven drug development paradigm was used to discover senolytic drugs. Based on the observation that senescent cells release factors that cause apoptosis of the cells around them, yet are themselves resistant to apoptosis, Dr. Kirkland hypothesized that senescent cells utilize senescent cell anti-apoptotic pathways (SCAPs) for protection from their own senescence-associated secretory phenotype (SASP). Using bioinformatics analyses of senescent vs. non-senescent cells and RNA interference, Dr. Kirkland identified these SCAPs and verified their importance for senescent cell survival. Dr. Kirkland used bioinformatics approaches to identify agents that target key nodes across the SCAP network and demonstrated these drugs are senolytic in rodent and human cultured cells and mice in vivo. These senolytic drugs include Dasatinib (D), Quercetin (Q), Fisetin, Navitoclax, and related compounds. Dr. Kirkland showed these agents delay, prevent, or alleviate multiple disorders in mouse models of human chronic diseases and aging phenotypes. Conditions alleviated in mouse models include frailty, diabetes, hepatic steatosis, cirrhosis, renal dysfunction, neuropsychiatric disorders, dementias, pulmonary fibrosis, osteoporosis, osteoarthritis, retinal degeneration, diastolic dysfunction, cardiac ischemia, vascular hyporeactivity, infertility, and skin disorders, among others. He demonstrated that intermittent, orally administered senolytics reduce senescent cell abundance in adipose tissue and blood markers of senescent cell burden in blood of patients with diabetic kidney disease. He and collaborators found that a brief course of senolytics enhances physical function and reduces frailty in patients with idiopathic pulmonary fibrosis, a fatal, cellular-senescence-driven disease for which available treatments have been unsatisfactory. Multiple clinical trials are currently underway of the senolytics that Dr. Kirkland discovered. He is a scientific advisory board member for several companies and academic organizations. In addition to being President-Elect of AFAR, he has been a member of the National Advisory Council on Aging of the National Institutes of Health, and past chair of the Biological Sciences Section of the Gerontological Society of America. He holds honorary appointments at Boston University and the University of Groningen in the Netherlands. He is a board-certified specialist in internal medicine, geriatrics, and endocrinology and metabolism. If you would like to support our channel, we'd love a coffee ☕…thank you! https://www.buymeacoffee.com/mhealthspan You can also find us on YouTube at https://www.youtube.com/c/modernhealthspan

america director university health netherlands conditions national institutes boston university elect mayo clinic rna kirkland groningen afar aging research national advisory council gerontological society james kirkland sasp fisetin

Lifestyles To Reduce Senescent Burden & Measuring Panel Dr. James Kirkland Interview Series Ep 5

Play Episode Listen Later Mar 6, 2022 8:00

In this video Dr. Kirkland talks about what we can do to reduce our senescent cell burden with lifestyle choices and how there is a grouping of health organizations measuring health markers across multiple trials to gather data on aging. Dr. James Kirkland is Director of the Robert and Arlene Kogod Center on Aging at Mayo Clinic and Noaber Foundation Professor of Aging Research. Dr. Kirkland's research focuses on cellular senescence, age-related adipose tissue and metabolic dysfunction, and development of agents and strategies for targeting fundamental aging mechanisms to treat age-related chronic diseases and disabilities and to extend healthspan. He published the first article about drugs that clear senescent cells, senolytic agents. A novel, mechanism-based, hypothesis-driven drug development paradigm was used to discover senolytic drugs. Based on the observation that senescent cells release factors that cause apoptosis of the cells around them, yet are themselves resistant to apoptosis, Dr. Kirkland hypothesized that senescent cells utilize senescent cell anti-apoptotic pathways (SCAPs) for protection from their own senescence-associated secretory phenotype (SASP). Using bioinformatics analyses of senescent vs. non-senescent cells and RNA interference, Dr. Kirkland identified these SCAPs and verified their importance for senescent cell survival. Dr. Kirkland used bioinformatics approaches to identify agents that target key nodes across the SCAP network and demonstrated these drugs are senolytic in rodent and human cultured cells and mice in vivo. These senolytic drugs include Dasatinib (D), Quercetin (Q), Fisetin, Navitoclax, and related compounds. Dr. Kirkland showed these agents delay, prevent, or alleviate multiple disorders in mouse models of human chronic diseases and aging phenotypes. Conditions alleviated in mouse models include frailty, diabetes, hepatic steatosis, cirrhosis, renal dysfunction, neuropsychiatric disorders, dementias, pulmonary fibrosis, osteoporosis, osteoarthritis, retinal degeneration, diastolic dysfunction, cardiac ischemia, vascular hyporeactivity, infertility, and skin disorders, among others. He demonstrated that intermittent, orally administered senolytics reduce senescent cell abundance in adipose tissue and blood markers of senescent cell burden in blood of patients with diabetic kidney disease. He and collaborators found that a brief course of senolytics enhances physical function and reduces frailty in patients with idiopathic pulmonary fibrosis, a fatal, cellular-senescence-driven disease for which available treatments have been unsatisfactory. Multiple clinical trials are currently underway of the senolytics that Dr. Kirkland discovered. He is a scientific advisory board member for several companies and academic organizations. In addition to being President-Elect of AFAR, he has been a member of the National Advisory Council on Aging of the National Institutes of Health, and past chair of the Biological Sciences Section of the Gerontological Society of America. He holds honorary appointments at Boston University and the University of Groningen in the Netherlands. He is a board-certified specialist in internal medicine, geriatrics, and endocrinology and metabolism. If you would like to support our channel, we'd love a coffee ☕…thank you! https://www.buymeacoffee.com/mhealthspan You can also find us on YouTube at https://www.youtube.com/c/modernhealthspan

Fisetin, Quercetin & Dasatinib in Clinical Trials Dr. James Kirkland Interview Series Ep 4

Play Episode Listen Later Mar 2, 2022 10:08

In this video Dr. Kirkland talks about the senolytics that the Mayo Clinic is using in the on going trials, dasatinib, Fisetin and Quercetin. He also talks about the way the work and the schedule to taking them Dr. James Kirkland is Director of the Robert and Arlene Kogod Center on Aging at Mayo Clinic and Noaber Foundation Professor of Aging Research. Dr. Kirkland's research focuses on cellular senescence, age-related adipose tissue and metabolic dysfunction, and development of agents and strategies for targeting fundamental aging mechanisms to treat age-related chronic diseases and disabilities and to extend healthspan. He published the first article about drugs that clear senescent cells, senolytic agents. A novel, mechanism-based, hypothesis-driven drug development paradigm was used to discover senolytic drugs. Based on the observation that senescent cells release factors that cause apoptosis of the cells around them, yet are themselves resistant to apoptosis, Dr. Kirkland hypothesized that senescent cells utilize senescent cell anti-apoptotic pathways (SCAPs) for protection from their own senescence-associated secretory phenotype (SASP). Using bioinformatics analyses of senescent vs. non-senescent cells and RNA interference, Dr. Kirkland identified these SCAPs and verified their importance for senescent cell survival. Dr. Kirkland used bioinformatics approaches to identify agents that target key nodes across the SCAP network and demonstrated these drugs are senolytic in rodent and human cultured cells and mice in vivo. These senolytic drugs include Dasatinib (D), Quercetin (Q), Fisetin, Navitoclax, and related compounds. Dr. Kirkland showed these agents delay, prevent, or alleviate multiple disorders in mouse models of human chronic diseases and aging phenotypes. Conditions alleviated in mouse models include frailty, diabetes, hepatic steatosis, cirrhosis, renal dysfunction, neuropsychiatric disorders, dementias, pulmonary fibrosis, osteoporosis, osteoarthritis, retinal degeneration, diastolic dysfunction, cardiac ischemia, vascular hyporeactivity, infertility, and skin disorders, among others. He demonstrated that intermittent, orally administered senolytics reduce senescent cell abundance in adipose tissue and blood markers of senescent cell burden in blood of patients with diabetic kidney disease. He and collaborators found that a brief course of senolytics enhances physical function and reduces frailty in patients with idiopathic pulmonary fibrosis, a fatal, cellular-senescence-driven disease for which available treatments have been unsatisfactory. Multiple clinical trials are currently underway of the senolytics that Dr. Kirkland discovered. He is a scientific advisory board member for several companies and academic organizations. In addition to being President-Elect of AFAR, he has been a member of the National Advisory Council on Aging of the National Institutes of Health, and past chair of the Biological Sciences Section of the Gerontological Society of America. He holds honorary appointments at Boston University and the University of Groningen in the Netherlands. He is a board-certified specialist in internal medicine, geriatrics, and endocrinology and metabolism. If you would like to support our channel, we'd love a coffee ☕…thank you! https://www.buymeacoffee.com/mhealthspan You can also find us on YouTube at https://www.youtube.com/c/modernhealthspan

Senescent Cells Effect & Benefits of Removing Dr James Kirkland Interview Series Ep 3

Play Episode Listen Later Feb 26, 2022 13:35

In this video Dr. Kirkland talks about how and why senescent cells are formed, how they can be removed and what the benefits of removing them is. Dr. James Kirkland is Director of the Robert and Arlene Kogod Center on Aging at Mayo Clinic and Noaber Foundation Professor of Aging Research. Dr. Kirkland's research focuses on cellular senescence, age-related adipose tissue and metabolic dysfunction, and development of agents and strategies for targeting fundamental aging mechanisms to treat age-related chronic diseases and disabilities and to extend healthspan. He published the first article about drugs that clear senescent cells, senolytic agents. A novel, mechanism-based, hypothesis-driven drug development paradigm was used to discover senolytic drugs. Based on the observation that senescent cells release factors that cause apoptosis of the cells around them, yet are themselves resistant to apoptosis, Dr. Kirkland hypothesized that senescent cells utilize senescent cell anti-apoptotic pathways (SCAPs) for protection from their own senescence-associated secretory phenotype (SASP). Using bioinformatics analyses of senescent vs. non-senescent cells and RNA interference, Dr. Kirkland identified these SCAPs and verified their importance for senescent cell survival. Dr. Kirkland used bioinformatics approaches to identify agents that target key nodes across the SCAP network and demonstrated these drugs are senolytic in rodent and human cultured cells and mice in vivo. These senolytic drugs include Dasatinib (D), Quercetin (Q), Fisetin, Navitoclax, and related compounds. Dr. Kirkland showed these agents delay, prevent, or alleviate multiple disorders in mouse models of human chronic diseases and aging phenotypes. Conditions alleviated in mouse models include frailty, diabetes, hepatic steatosis, cirrhosis, renal dysfunction, neuropsychiatric disorders, dementias, pulmonary fibrosis, osteoporosis, osteoarthritis, retinal degeneration, diastolic dysfunction, cardiac ischemia, vascular hyporeactivity, infertility, and skin disorders, among others. He demonstrated that intermittent, orally administered senolytics reduce senescent cell abundance in adipose tissue and blood markers of senescent cell burden in blood of patients with diabetic kidney disease. He and collaborators found that a brief course of senolytics enhances physical function and reduces frailty in patients with idiopathic pulmonary fibrosis, a fatal, cellular-senescence-driven disease for which available treatments have been unsatisfactory. Multiple clinical trials are currently underway of the senolytics that Dr. Kirkland discovered. He is a scientific advisory board member for several companies and academic organizations. In addition to being President-Elect of AFAR, he has been a member of the National Advisory Council on Aging of the National Institutes of Health, and past chair of the Biological Sciences Section of the Gerontological Society of America. He holds honorary appointments at Boston University and the University of Groningen in the Netherlands. He is a board-certified specialist in internal medicine, geriatrics, and endocrinology and metabolism. If you would like to support our channel, we'd love a coffee ☕…thank you! https://www.buymeacoffee.com/mhealthspan You can also find us on YouTube at https://www.youtube.com/c/modernhealthspan

What Are Senescent Cells Dr James Kirkland Interview Series Ep 2

toronto raptors tooth claw james kirkland

Play Episode Listen Later Feb 23, 2022 11:32

In this video Dr. Kirkland gives a wide introduction to senescent cells including why we have them, what purpose they serve and what damage they can cause. Dr. James Kirkland is Director of the Robert and Arlene Kogod Center on Aging at Mayo Clinic and Noaber Foundation Professor of Aging Research. Dr. Kirkland's research focuses on cellular senescence, age-related adipose tissue and metabolic dysfunction, and development of agents and strategies for targeting fundamental aging mechanisms to treat age-related chronic diseases and disabilities and to extend healthspan. He published the first article about drugs that clear senescent cells, senolytic agents. A novel, mechanism-based, hypothesis-driven drug development paradigm was used to discover senolytic drugs. Based on the observation that senescent cells release factors that cause apoptosis of the cells around them, yet are themselves resistant to apoptosis, Dr. Kirkland hypothesized that senescent cells utilize senescent cell anti-apoptotic pathways (SCAPs) for protection from their own senescence-associated secretory phenotype (SASP). Using bioinformatics analyses of senescent vs. non-senescent cells and RNA interference, Dr. Kirkland identified these SCAPs and verified their importance for senescent cell survival. Dr. Kirkland used bioinformatics approaches to identify agents that target key nodes across the SCAP network and demonstrated these drugs are senolytic in rodent and human cultured cells and mice in vivo. These senolytic drugs include Dasatinib (D), Quercetin (Q), Fisetin, Navitoclax, and related compounds. Dr. Kirkland showed these agents delay, prevent, or alleviate multiple disorders in mouse models of human chronic diseases and aging phenotypes. Conditions alleviated in mouse models include frailty, diabetes, hepatic steatosis, cirrhosis, renal dysfunction, neuropsychiatric disorders, dementias, pulmonary fibrosis, osteoporosis, osteoarthritis, retinal degeneration, diastolic dysfunction, cardiac ischemia, vascular hyporeactivity, infertility, and skin disorders, among others. He demonstrated that intermittent, orally administered senolytics reduce senescent cell abundance in adipose tissue and blood markers of senescent cell burden in blood of patients with diabetic kidney disease. He and collaborators found that a brief course of senolytics enhances physical function and reduces frailty in patients with idiopathic pulmonary fibrosis, a fatal, cellular-senescence-driven disease for which available treatments have been unsatisfactory. Multiple clinical trials are currently underway of the senolytics that Dr. Kirkland discovered. He is a scientific advisory board member for several companies and academic organizations. In addition to being President-Elect of AFAR, he has been a member of the National Advisory Council on Aging of the National Institutes of Health, and past chair of the Biological Sciences Section of the Gerontological Society of America. He holds honorary appointments at Boston University and the University of Groningen in the Netherlands. He is a board-certified specialist in internal medicine, geriatrics, and endocrinology and metabolism. If you would like to support our channel, we'd love a coffee ☕…thank you! https://www.buymeacoffee.com/mhealthspan You can also find us on YouTube at https://www.youtube.com/c/modernhealthspan

Episode #49 Raptors red in tooth and claw with James Kirkland

Paleo Nerds

Play Episode Listen Later Feb 22, 2022 74:09

The nerds talk Utahraptors with Utah State Paleontologist Jim Kirkland.

My Theory Of Aging & Unitary Theory Of Fundamental Aging - Dr James Kirkland Interview Series Ep1

Play Episode Listen Later Feb 20, 2022 8:21

In this video Dr. Kirkland explains his theory of aging and discusses the Unitary Theory of Fundamental Aging, which posits that there are underlying pillars of aging which cause the diseases of aging and that are interlinked. Dr. Kirkland offers some examples of these linkages Dr. James Kirkland is Director of the Robert and Arlene Kogod Center on Aging at Mayo Clinic and Noaber Foundation Professor of Aging Research. Dr. Kirkland's research focuses on cellular senescence, age-related adipose tissue and metabolic dysfunction, and development of agents and strategies for targeting fundamental aging mechanisms to treat age-related chronic diseases and disabilities and to extend healthspan. He published the first article about drugs that clear senescent cells, senolytic agents. A novel, mechanism-based, hypothesis-driven drug development paradigm was used to discover senolytic drugs. Based on the observation that senescent cells release factors that cause apoptosis of the cells around them, yet are themselves resistant to apoptosis, Dr. Kirkland hypothesized that senescent cells utilize senescent cell anti-apoptotic pathways (SCAPs) for protection from their own senescence-associated secretory phenotype (SASP). Using bioinformatics analyses of senescent vs. non-senescent cells and RNA interference, Dr. Kirkland identified these SCAPs and verified their importance for senescent cell survival. Dr. Kirkland used bioinformatics approaches to identify agents that target key nodes across the SCAP network and demonstrated these drugs are senolytic in rodent and human cultured cells and mice in vivo. These senolytic drugs include Dasatinib (D), Quercetin (Q), Fisetin, Navitoclax, and related compounds. Dr. Kirkland showed these agents delay, prevent, or alleviate multiple disorders in mouse models of human chronic diseases and aging phenotypes. Conditions alleviated in mouse models include frailty, diabetes, hepatic steatosis, cirrhosis, renal dysfunction, neuropsychiatric disorders, dementias, pulmonary fibrosis, osteoporosis, osteoarthritis, retinal degeneration, diastolic dysfunction, cardiac ischemia, vascular hyporeactivity, infertility, and skin disorders, among others. He demonstrated that intermittent, orally administered senolytics reduce senescent cell abundance in adipose tissue and blood markers of senescent cell burden in blood of patients with diabetic kidney disease. He and collaborators found that a brief course of senolytics enhances physical function and reduces frailty in patients with idiopathic pulmonary fibrosis, a fatal, cellular-senescence-driven disease for which available treatments have been unsatisfactory. Multiple clinical trials are currently underway of the senolytics that Dr. Kirkland discovered. He is a scientific advisory board member for several companies and academic organizations. In addition to being President-Elect of AFAR, he has been a member of the National Advisory Council on Aging of the National Institutes of Health, and past chair of the Biological Sciences Section of the Gerontological Society of America. He holds honorary appointments at Boston University and the University of Groningen in the Netherlands. He is a board-certified specialist in internal medicine, geriatrics, and endocrinology and metabolism. If you would like to support our channel, we'd love a coffee ☕…thank you! https://www.buymeacoffee.com/mhealthspan You can also find us on YouTube at https://www.youtube.com/c/modernhealthspan

Super Bowl LVI Recap

michigan state university cincinnati bengals super bowl lvi james kirkland

Play Episode Listen Later Feb 16, 2022 65:29

Former NFL Scout David Turner is joined by Michigan State recruiting specialist James Kirkland to share their thoughts on the Los Angels Rams beating the Cincinnati Bengals in Super Bowl LVI

The dangerous side effect travelling to Mars could have on humans

3AW Breakfast with Ross and John

Play Episode Listen Later Jan 3, 2022 5:52

Director of the Robert and Arlene Kogod Center on Aging at Mayo Clinic, Dr James Kirkland, says there are fears the trip could have a dangerous impact on humans. See omnystudio.com/listener for privacy information.

director mars humans dangerous travelling mayo clinic side effects james kirkland

Ann Wolfe 'Life Story'

BoXing Daily 'Life Stories'

Play Episode Listen Later Jul 23, 2021 9:34

She is an American former boxer who held world titles in three different weight classes simultaneously. Wolfe is regarded by many within the sport as one of the greatest female boxers of all time. Wolfe early Life was very rough, she was molested as a preteen,. She was a dropout unable to read or write when her mom died. That same year, her father was killed. Her brother was also killed in an attempted robbery. Another is serving a life sentence. Furthermore, She served 18 months in Prison on a Drug Charge. After that, living a straight life didn't come easy. With two young daughters, Wolfe tried to provide in any way she could. The result was a year spent working construction during the day and being homeless through the night. Wolfe and her daughters lived under a boat in a desolate parking lot. She also was a personal trainer and coach of several professional boxers, including former light middleweight contender James Kirkland. She appears in the 2017 film Wonder Woman in the supporting role of the Amazon Artemis.

american prison wonder woman wolfe james kirkland

NCAA Supreme Court Ruling, NIL, and the Transfer Portal

nfl recruiting college football james kirkland

Play Episode Listen Later Jul 1, 2021 62:26

David Turner and James Kirkland talk all the latest buzz for college football, specifically the NCAA Supreme Court Ruling, Name Image and Likeness, and the Transfer Portal.

ncaa likeness transfer portal supreme court ruling david turner james kirkland ncaa supreme court

Episode 122: James Kirkland on targeting senescent cells to reverse age-related diseases

STEM-Talk

Play Episode Listen Later May 6, 2021 55:38

In today’s episode, we talk about zombie cells, a term used to describe senescent cells because of their refusal to die. Our guest on this topic is Dr. James Kirkland, a geriatrics specialist and researcher at the Mayo Clinic in Rochester, Minnesota, who is known for his research into the role that senescence and senescent cells have on age-related dysfunction and chronic disease. As senescent cells build up in the body, they promote cellular aging and a host of chronic conditions related to aging, such as dementia, cancer, atherosclerosis, diabetes and arthritis. In today’s interview, we focus on Jim’s 2015 study where he and his colleagues at Mayo were the first to report on the potential of senolytic drugs to selectively kill zombie senescent cells. Jim’s paper in Aging Cell has been hailed as a major breakthrough in aging research. Jim is the director of the Robert and Arlene Kogod Center of Aging at Mayo and the president of the American Federation for Aging Research. The goal of James’ lab and research is to develop methods to remove senescent cells to delay, prevent, alleviate or partially reverse age-related chronic diseases. Jim and his colleagues believe that doing this will help extend people’s health span, and, more important, prolong the period of life where people can live free of disabilities caused by chronic disease. Show notes: 00:03:20 Jim starts the interview talking about growing up in Canada. 00:03:31 Dawn asks him when he became interested in science. 00:04:05 Ken mentions that he understands that Jim had an interest in becoming a physician at a very early age, and given Jim’s previous comments, asks if it was Jim’s childhood observations of his grandparents’ aging that drove his interest in geriatrics. 00:04:39 Dawn asks how Jim ended up at the University of Toronto. 00:04:51 Dawn mentions that Jim received his medical degree in 1977 and completed his residency at Toronto General Hospital. Dawn goes on to ask why, after this, did Jim decide to go overseas to study at the University of Manchester. 00:05:37 Dawn mentions that after Jim’s experience in Manchester, he moved back across the Atlantic to work at the National Institutes of Health (NIH), where he mainly studied adipose tissue. 00:06:11 Dawn asks what role Jim’s research at NIH played in his Ph.D., which he earned from the University of Toronto in 1990. 00:07:19 Dawn mentions that in 2007 Jim became the director of the Kogod Center on Aging at the Mayo Clinic and asks how Jim ended up at that position. 00:07:54 Dawn asks Jim to clarify the difference between lifespan and healthspan. 00:09:26 Ken mentions that Jim’s research throughout his career has focused on cellular aging and senescent cells. Ken asks what initially triggered Jim’s interest in senescence. 00:11:42 Dawn mentions Jim’s 2015 paper in Aging Cell, where Jim and his colleagues at the Mayo Clinic were the first to report on the potential of senolytic drugs, which selectively kill senescent cells. Dawn goes on to ask Jim about his research leading up to this breakthrough paper. 00:14:47 Dawn asks Jim to talk about two senolytic compounds that he and his colleagues identified called dasatinid and quercetin, and what the significance of their discovery is. 00:17:20 Ken mentions the senolytic agent called fisetin, which is another agent showing benefit in rodent studies and is now being used in human clinical trials. Ken mentions that some authors have described fisetin as having roughly twice the senolytic potency as quercetin. Ken asks Jim to explain where fisetin fits into the senolytic landscape. 00:19:18 Dawn mentions that Jim began his aforementioned 2015 paper by writing about how the research shows that the healthspan of mice is enhanced by killing senescent cells using a transgenic suicide gene. Jim goes on in that paper describing how a series of experiments by he and his colleagues demonstrated the efficacy of senolytics t...

Episode 2: College Football recruiting

Mavs Sports take

Play Episode Listen Later Mar 20, 2021 87:01

Discussion about the business of football "on and off the field" with former NFL players James Kirkland and Quinton Ganther.

Remixed Classic Soul episode 18

Remixed Classic Soul

Play Episode Listen Later Feb 19, 2021 61:28

Classic soul music that's been remixed re-edited reshaped and re-loved by today's most gifted DJs and producers from around the world. "Quality Edits for Beautiful People" Episode 18 features song's by: Jimmy Smith, James Kirkland, Eunice Collins, Bilal, Gwen McCrae, The Fuzz, Joe Quarterman & Free Soul, Aretha Franklin, Steve Miller, Candi Staton, First Choice/ Sugarhill Gang, Billie Eilish, Let's Do This Jazz Thing Together

classic djs billie eilish aretha franklin bilal fuzz remixed steve miller jimmy smith candi staton classic soul gwen mccrae james kirkland

Episode 46 - James Kirkland

Victor Zheng's Friends

Play Episode Listen Later Feb 15, 2021 70:25

James talks about what it was like living in different countries, why he chose Texas A&M, his career path and aspirations, hobbies, and much more!!

james kirkland

Ask The Experts Podcast with Curran Bhatia - Episode 30

Ask The Experts Boxing Podcast with Curran Bhatia

Play Episode Listen Later Jan 15, 2021 64:13

Curran Bhatia interviews James Kirkland & Jeremiah GallegosFollow Ask The Experts:https://www.Twitter.com/ATE_Podcasthttps://www.Instagram.com/ATE_Podcasthttp://bit.ly/ATE_PODCASTAPPLE PODCASTS: https://apple.co/37M4jHnEmail: AskTheExpertsPod@gmail.comFollow Curran:https://www.Twitter.com/CurranBhatiahttps://www.Instagram.com/CurranBhatiahttps://www.Youtube.com/CurranBhatiaEmail: CurranBhatia@gmail.comCurran Bhatia is a four-time Emmy nominated fmr. Producer at HBO for nearly a decade. Since then, Curran has moved in front of the camera into on-air interviewing, hosting, announcing, and reporting. Curran has been featured in an on-air role on NBC Sports, FOX Sports, Bleacher Report Live (B/R LIVE), PlutoTV, fuboTV, UFC Fight Pass, and other outlets.Curran currently hosts an interview series looking at tech disruptors and highly successful leaders and hosts the Ask The Experts Podcast, which was rated the #1 boxing podcast in September 2019.Ask The Experts Podcast with Curran Bhatia - Episode 30 See acast.com/privacy for privacy and opt-out information.

hbo fox sports nbc sports curran pluto tv bhatia ufc fight pass ask the experts fubotv james kirkland

Episode 175: Ring Gang Radio Presents "Real Talk": James Kirkland: A potential never fulfilled / PBC on FOX in 2020 = FAIL!!!

Ring Gang Radio's Podcasts

Play Episode Listen Later Dec 30, 2020 23:38

sports podcasts ring fail fight gang fights boxing real talk fulfilled radios pbc james kirkland ring gang

The Stack up show/LIITR {two shows in one}

Leave it in the Ring Radio

Play Episode Listen Later Dec 30, 2020 126:00

The Stack Up show - We discuss how certain fighters from different eras of the sport Stack Up against the current fighters of today . Joe Calzaghe is 1st up on discussing how he fairs with the elite in the 168 suoer-middleweight division . Would Joe hand speed puzzle the likes of Canelo ? Could he out land bullish power hitter Benavidez? Then we turn the discussion to 1994 WBA welterweight champion Ike Quartey how does he stack up to the current crop of fighters of today . LIITR Monday sow is included ,we discuss the Saturday Garcia vs Campbell shiwdown on Dazn . Give our pick & breakdown between the two fighters, we ask whether James Kirkland should finally hang up the gloves, and we look into the comment by journalist Mark Kriegel that Loma was too small against Lopez.

campbell boxing lopez sports talk canelo alvarez dazn wba stack up loma benavidez two shows james kirkland boxing radio mark kriegel

James Kirkland: A potential never fulfilled / PBC on FOX in 2020 = FAIL!!!

Ring Gang Radio Podcasts

Play Episode Listen Later Dec 30, 2020 24:34

On this segment of "Real Talk", The Ring Gang crew and guest Kese Soprano discuss recap the recent defeat of James Kirkland while giving scathing criticism to the final PBC on FOX card for 2020 as well as the majority of PBC on FOX cards that have aired this year. --- This episode is sponsored by · Anchor: The easiest way to make a podcast. https://anchor.fm/app --- Send in a voice message: https://anchor.fm/rgradio/message Support this podcast: https://anchor.fm/rgradio/support

fail real talk fulfilled pbc james kirkland ring gang

Charles Conwell vs Madiyar Ashkeyev Recap / James Kirkland Returns

Ring Gang Radio Podcasts

Play Episode Listen Later Dec 24, 2020 40:11

On this segment of "Real Talk", the Ring Gang crew recap the Ring City main event between Charles Conwell and Madiyar Ashkeyev as well discuss the PBC debut of James Kirkland. --- This episode is sponsored by · Anchor: The easiest way to make a podcast. https://anchor.fm/app --- Send in a voice message: https://anchor.fm/rgradio/message Support this podcast: https://anchor.fm/rgradio/support

real talk pbc conwell james kirkland ring gang

Episode 172: Ring Gang Radio Presents "Real Talk": Charles Conwell vs Madiyar Ashkeyev Recap / James Kirkland Returns

Ring Gang Radio's Podcasts

Play Episode Listen Later Dec 24, 2020 39:15

On this segment of "Real Talk", the Ring Gang crew recap the Ring City main event between Charles Conwell and Madiyar Ashkeyev as well discuss the PBC debut of James Kirkland.

sports podcasts ring fight gang fights boxing real talk radios pbc conwell james kirkland ring gang

Jamal James, James Kirkland & The Return of Canelo

The PBC Podcast

Play Episode Listen Later Dec 23, 2020 62:55

WBA Interim World Welterweight Champion Jamal James drops by to discuss a roller coaster year and what's in store for 2021. Also, we look ahead to boxing on Boxing Day as Saturday night's FOX PBC Fight Night card which features the return of "The Mandingo Warrior," James Kirkland. Plus, a look back at all of last week's action, including the return of Canelo Alvarez--and we propose the fighters we believe can beat him in our Toe to Toe section. For show notes and more info, click here: https://www.premierboxingchampions.com/podcast

night champions fight premier boxing showtime alvarez boxing day canelo alvarez kirkland toe pbc james james james kirkland jamal james

College Football Recruiting Roundtable with James Kirkland and Quinton Ganther

director nfl illinois utah roundtable recruiting college football player personnel weber state nfl scouts james kirkland

Play Episode Listen Later Sep 23, 2020 87:01

Mavs Sports Take brings on a college football duo to discuss the pandemic’s impact on recruiting: hear from Quinton Ganther, former NFL running back, Utah standout and current coach at Weber State, and James Kirkland, an ex-NFL Scout and current Director of Player Personnel for Illinois.

20.6.2 - Shatterkin - Prison Break!

table dark gm dice wordpress forged prison break john harper james kirkland

Play Episode Listen Later Sep 14, 2020 25:34

Welcome to Around the Table in 80 Dice! You’re listening to our special playtest campaign of Shatterkin Evolutions — an rpg in development by Scribbles & Dice Games, using a variation of John Harper’s Forged in the Dark system. The following episode is part of a short campaign that was done as the first playtest of Shatterkin. If you’d like to give Shatterkin a try, yourself, you can find it on the indie-games hosting site, itch.io Shatterkin is a game about a group of children who have bonded with strange evolving monsters. We play to discover how this bond between child and monster will help both of them grow, as they deal with dangers, mysteries, adventures, and the troubles of growing up. In this episode, the friends and their shatterkin stage a Prison Break to rescue Harrison. The GM for the campaign was Scott Krammer, and the players were Caleb Wall, Miriam Scott, Nicole Krammer, James Kirkland, and Jessica Wall. 80Dice.Wordpress.com The Nerdd Network TheNerdd.com

Just a SEC: Corporate relations, networking tips and international internships (Featuring James Kirkland)

Texas A&M Engineering: SoundBytes

Play Episode Listen Later Sep 8, 2020 14:04 Transcription Available

Looking for tips and tricks on how to reach out to companies and make professional connections? Are you searching for an internship, but don't know where to start? Get an inside look into the world of professional networking with the former corporate relations co-chair of the Student Engineers' Council, James Kirkland, on this episode of Just a SEC.

leadership japan advice international engineering council sec internships student life tamu networking tips texas a&m soundbytes corporate relations james kirkland

Mav Sports Take: Exploring CFL Shutdown and College Football with James Kirkland

All Access Football Podcast Network

Play Episode Listen Later Sep 3, 2020 67:00

Mav Sports Take discusses the CFL shutdown and how it affects the development of young talent globally and gains true insight from the University of Illinois own Director of Player Personnel James Kirkland on what High School know about recruiting during COVID.

covid-19 director university illinois high school college football shutdowns cfl james kirkland

20.6.1 - Shatterkin - Leaf Blastin'

Play Episode Listen Later Sep 1, 2020 70:21

Welcome to Around the Table in 80 Dice! You’re listening to our special playtest campaign of Shatterkin Evolutions — an rpg in development by Scribbles & Dice Games, using a variation of John Harper’s Forged in the Dark system. The following episode is part of a short campaign that was done as the first playtest of Shatterkin. If you’d like to give Shatterkin a try, yourself, you can find it on the indie-games hosting site, itch.io Shatterkin is a game about a group of children who have bonded with strange evolving monsters. We play to discover how this bond between child and monster will help both of them grow, as they deal with dangers, mysteries, adventures, and the troubles of growing up. In this episode, the friends meet some peculiar members of the community, and begin their infiltration of the SPIRE facility. The GM for the campaign was Scott Krammer, and the players were Caleb Wall, Miriam Scott, Nicole Krammer, James Kirkland, and Jessica Wall. 80Dice.Wordpress.com The Nerdd Network TheNerdd.com

table dark gm dice wordpress leaf forged spire john harper james kirkland

Exploring the CFL shutdown and College football with James Kirkland

covid-19 director university illinois high school college football shutdowns globally cfl james kirkland

Play Episode Listen Later Aug 19, 2020 66:21

Mavs Sports Take discusses the CFL shutdown and how it affects the development of young talent Globally and gains true insight from the University of Illinois own Director of Player Personnel James Kirkland on what High School kids should know about recruiting during COVID.

20.5.3 - Shatterkin - I Chain It Up with My Hell Bird!

Play Episode Listen Later Aug 11, 2020 62:32

Welcome to Around the Table in 80 Dice! You’re listening to our special playtest campaign of Shatterkin Evolutions — an rpg in development by Scribbles & Dice Games, using a variation of John Harper’s Forged in the Dark system. The following episode is part of a short campaign that was done as the first playtest of Shatterkin. If you’d like to give Shatterkin a try, yourself, you can find it on the indie-games hosting site, itch.io Shatterkin is a game about a group of children who have bonded with strange evolving monsters. We play to discover how this bond between child and monster will help both of them grow, as they deal with dangers, mysteries, adventures, and the troubles of growing up. In this episode, a new friend is made in the midst of a crisis. The GM for the campaign was Scott Krammer, and the players were Caleb Wall, Miriam Scott, Nicole Krammer, James Kirkland, and Jessica Wall. 80Dice.Wordpress.com The Nerdd Network TheNerdd.com

hell table dark gm dice wordpress chain forged john harper james kirkland

20.5.2 - Shatterkin - The Malice Unveiled